Spruce Biosciences, Inc. Interest Expense
Spruce Biosciences, Inc. (SPRB) reported Interest Expense of $1.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2026-08-12
- Spruce Biosciences, Inc. interest expense for the quarter ending 2026-06-30 was $1.10M, a 3682.76% increase year-over-year.
- Spruce Biosciences, Inc. interest expense for the quarter ending 2026-03-31 was $674.00K, a 1772.22% increase year-over-year.
- Spruce Biosciences, Inc. interest expense for the quarter ending 2025-12-31 was $6.00K, a 89.29% decline year-over-year.
- Spruce Biosciences, Inc. interest expense for the quarter ending 2025-09-30 was $19.00K, a 73.24% decline year-over-year.
- Spruce Biosciences, Inc. interest expense for fiscal 2025 was $90.00K, a 70.68% decline from fiscal 2024.
- Spruce Biosciences, Inc. interest expense for fiscal 2024 was $307.00K, a 36.44% decline from fiscal 2023.
- Spruce Biosciences, Inc. interest expense for fiscal 2023 was $483.00K, a 15.00% increase from fiscal 2022.
- Spruce Biosciences, Inc. interest expense for fiscal 2022 was $420.00K, a 21.74% increase from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.10M 10-Q · filed 2026-08-12 | $1.77M 10-Q · filed 2026-08-12 | $1.78M derived: sum of 3 quarters · filed 2026-08-12 | $1.80M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $674.00K 10-Q · filed 2026-05-13 | $680.00K derived: sum of 2 quarters · filed 2026-05-13 | $699.00K derived: sum of 3 quarters · filed 2026-05-13 | $728.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $25.00K derived: sum of 2 quarters · filed 2026-03-09 | $54.00K derived: sum of 3 quarters · filed 2026-08-12 | $90.00K 10-K · filed 2026-03-09 |
| 2025-09-30 | $19.00K 10-Q · filed 2025-11-10 | $48.00K derived: sum of 2 quarters · filed 2026-08-12 | $84.00K 10-Q · filed 2025-11-10 | $140.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $29.00K 10-Q · filed 2026-08-12 | $65.00K 10-Q · filed 2026-08-12 | $121.00K derived: sum of 3 quarters · filed 2026-08-12 | $192.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $36.00K 10-Q · filed 2026-05-13 | $92.00K derived: sum of 2 quarters · filed 2026-05-13 | $163.00K derived: sum of 3 quarters · filed 2026-05-13 | $246.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $127.00K derived: sum of 2 quarters · filed 2026-03-09 | $210.00K derived: sum of 3 quarters · filed 2026-03-09 | $307.00K 10-K · filed 2026-03-09 |
| 2024-09-30 | $71.00K 10-Q · filed 2025-11-10 | $154.00K derived: sum of 2 quarters · filed 2025-11-10 | $251.00K 10-Q · filed 2025-11-10 | $357.00K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $83.00K 10-Q · filed 2025-08-14 | $180.00K 10-Q · filed 2025-08-14 | $286.00K derived: sum of 3 quarters · filed 2025-08-14 | $405.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $97.00K 10-Q · filed 2025-05-06 | $203.00K derived: sum of 2 quarters · filed 2025-05-06 | $322.00K derived: sum of 3 quarters · filed 2025-05-06 | $449.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $225.00K derived: sum of 2 quarters · filed 2025-04-15 | $352.00K derived: sum of 3 quarters · filed 2025-04-15 | $483.00K 10-K · filed 2025-04-15 |
| 2023-09-30 | $119.00K 10-Q · filed 2024-11-12 | $246.00K derived: sum of 2 quarters · filed 2024-11-12 | $377.00K 10-Q · filed 2024-11-12 | $506.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $127.00K 10-Q · filed 2024-08-12 | $258.00K 10-Q · filed 2024-08-12 | $387.00K derived: sum of 3 quarters · filed 2024-08-12 | $497.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $131.00K 10-Q · filed 2024-05-13 | $260.00K derived: sum of 2 quarters · filed 2024-05-13 | $370.00K derived: sum of 3 quarters · filed 2024-05-13 | $464.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $239.00K derived: sum of 2 quarters · filed 2024-03-18 | $333.00K derived: sum of 3 quarters · filed 2024-03-18 | $420.00K 10-K · filed 2024-03-18 |
| 2022-09-30 | $110.00K 10-Q · filed 2023-11-13 | $204.00K derived: sum of 2 quarters · filed 2023-11-13 | $291.00K 10-Q · filed 2023-11-13 | $379.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $94.00K 10-Q · filed 2023-08-14 | $181.00K 10-Q · filed 2023-08-14 | $269.00K derived: sum of 3 quarters · filed 2023-08-14 | $357.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $87.00K 10-Q · filed 2023-05-15 | $175.00K derived: sum of 2 quarters · filed 2023-05-15 | $263.00K derived: sum of 3 quarters · filed 2023-05-15 | $343.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $176.00K derived: sum of 2 quarters · filed 2023-03-16 | $256.00K derived: sum of 3 quarters · filed 2023-03-16 | $345.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $88.00K 10-Q · filed 2022-11-10 | $168.00K derived: sum of 2 quarters · filed 2022-11-10 | $257.00K 10-Q · filed 2022-11-10 | $335.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $80.00K 10-Q · filed 2022-08-10 | $169.00K 10-Q · filed 2022-08-10 | $247.00K derived: sum of 3 quarters · filed 2022-08-10 | $326.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $89.00K 10-Q · filed 2022-05-11 | $167.00K derived: sum of 2 quarters · filed 2022-05-11 | $246.00K derived: sum of 3 quarters · filed 2022-05-11 | $338.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $157.00K derived: sum of 2 quarters · filed 2022-03-14 | $249.00K derived: sum of 3 quarters · filed 2022-03-14 | $323.00K 10-K · filed 2022-03-14 |
| 2020-09-30 | $79.00K 10-Q · filed 2021-11-15 | $171.00K derived: sum of 2 quarters · filed 2021-11-15 | $245.00K 10-Q · filed 2021-11-15 | $305.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $92.00K 10-Q · filed 2021-08-10 | $166.00K 10-Q · filed 2021-08-10 | $226.00K derived: sum of 3 quarters · filed 2021-08-10 | $231.00K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $74.00K 10-Q · filed 2021-05-12 | $134.00K derived: sum of 2 quarters · filed 2021-05-12 | $139.00K derived: sum of 3 quarters · filed 2021-05-12 | |
| 2019-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $65.00K derived: sum of 2 quarters · filed 2021-03-22 | $65.00K 10-K · filed 2021-03-22 | |
| 2019-09-30 | $5.00K 10-Q · filed 2020-11-18 | $5.00K 10-Q · filed 2020-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |